Literature DB >> 21355049

Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson's disease.

Guang Shi1, Jeffrey R Lee, David A Grimes, Lemuel Racacho, David Ye, Howard Yang, Owen A Ross, Matthew Farrer, G Angus McQuibban, Dennis E Bulman.   

Abstract

Molecular genetics has linked mitochondrial dysfunction to the pathogenesis of Parkinson's disease by the discovery of rare, inherited mutations in gene products that associate with the mitochondria. Mutations in PTEN-induced kinase-1 (PINK1), which encodes a mitochondrial kinase, and PARKIN, encoding an E3 ubiquitin ligase, are the most frequent causes of recessive Parkinson's disease. Recent functional studies have revealed that PINK1 recruits PARKIN to mitochondria to initiate mitophagy, an important autophagic quality control mechanism that rids the cell of damaged mitochondria. PINK1 is post-translationally processed into a cleaved form whose levels are tightly regulated, although the significance of this processing is unknown. Here we demonstrate that the mitochondrial protease presenilin-associated rhomboid-like (PARL) can affect the proteolytic processing of PINK1 and that normal PINK1 localization and stability requires PARL's catalytic activity. PARL deficiency impairs PARKIN recruitment to mitochondria, suggesting PINK1's processing and localization are important in determining its interaction with PARKIN. We sequenced the PARL gene in Parkinson's disease patients and discovered a novel missense mutation in a functional domain of PARL's N-terminus. This PARL mutant is not sufficient to rescue PARKIN recruitment, suggesting that impaired mitophagy may be an underlying mechanism of disease pathogenesis in patients with PARL mutations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21355049     DOI: 10.1093/hmg/ddr077

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  55 in total

Review 1.  Mitochondrial dynamics and mitophagy in Parkinson's disease: disordered cellular power plant becomes a big deal in a major movement disorder.

Authors:  Yuzuru Imai; Bingwei Lu
Journal:  Curr Opin Neurobiol       Date:  2011-11-01       Impact factor: 6.627

2.  PINK1- and Parkin-mediated mitophagy at a glance.

Authors:  Seok Min Jin; Richard J Youle
Journal:  J Cell Sci       Date:  2012-02-15       Impact factor: 5.285

3.  A comprehensive glossary of autophagy-related molecules and processes (2nd edition).

Authors:  Daniel J Klionsky; Eric H Baehrecke; John H Brumell; Charleen T Chu; Patrice Codogno; Ana Marie Cuervo; Jayanta Debnath; Vojo Deretic; Zvulun Elazar; Eeva-Liisa Eskelinen; Steven Finkbeiner; Juan Fueyo-Margareto; David Gewirtz; Marja Jäättelä; Guido Kroemer; Beth Levine; Thomas J Melia; Noboru Mizushima; David C Rubinsztein; Anne Simonsen; Andrew Thorburn; Michael Thumm; Sharon A Tooze
Journal:  Autophagy       Date:  2011-11-01       Impact factor: 16.016

Review 4.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

5.  Down-regulation of the mitochondrial matrix peptidase ClpP in muscle cells causes mitochondrial dysfunction and decreases cell proliferation.

Authors:  Sathyaseelan S Deepa; Shylesh Bhaskaran; Rojina Ranjit; Rizwan Qaisar; Binoj C Nair; Yuhong Liu; Michael E Walsh; Wilson C Fok; Holly Van Remmen
Journal:  Free Radic Biol Med       Date:  2015-12-23       Impact factor: 7.376

Review 6.  PINK1 as a molecular checkpoint in the maintenance of mitochondrial function and integrity.

Authors:  Hyongjong Koh; Jongkyeong Chung
Journal:  Mol Cells       Date:  2012-05-18       Impact factor: 5.034

7.  PARL and HtrA2: another intricate ischemic neuronal apoptotic process starting within mitochondria.

Authors:  Chung Y Hsu
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-07       Impact factor: 6.200

8.  PINK1 is degraded through the N-end rule pathway.

Authors:  Koji Yamano; Richard J Youle
Journal:  Autophagy       Date:  2013-04-17       Impact factor: 16.016

9.  Membrane cholesterol as regulator of human rhomboid protease RHBDL4.

Authors:  Sandra Paschkowsky; Sherilyn Junelle Recinto; Jason C Young; Ana-Nicoleta Bondar; Lisa Marie Munter
Journal:  J Biol Chem       Date:  2018-08-24       Impact factor: 5.157

10.  Alternative Processing of the Amyloid Precursor Protein Family by Rhomboid Protease RHBDL4.

Authors:  Sandra Paschkowsky; Mehdi Hamzé; Felix Oestereich; Lisa Marie Munter
Journal:  J Biol Chem       Date:  2016-08-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.